A Phase 1 Study of [225Ac]-FPI-1434 Injection

Clinical trial NCT03746431 · TERMINATED

Trial details

NCT number: NCT03746431
Sponsor: Fusion Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours Endometrial Cancer Cervical Cancer Ovarian Cancer Breast Cancer Triple Negative Breast Cancer (TNBC)HER2-negative Breast Cancer Head and Neck Squamous Cell Carcinoma (HNSCC)Adrenocortical Carcinoma Uveal Melanoma

Start date: 2019-01-17
Primary completion: 2025-12-03
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.